Vascular endothelial growth factor and the collateral circulation: The story continues

Circulation Research

Volumn 103, Issue 9, 2008, Pages 905-906

  Chilian, William M ^a   Pung, Yuh Fen ^a  

^a Northeast Ohio Medical University   (United States)

Author keywords

Collateral circulation; Growth factors

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; CIRCULATION; EDITORIAL; HEART INFARCTION; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; STROKE; ANIMAL; BLOOD FLOW; BRAIN CIRCULATION; CEREBRAL ARTERY DISEASE; COLLATERAL CIRCULATION; DISEASE MODEL; GENETICS; ISCHEMIA; METABOLISM; MOUSE; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSGENIC MOUSE; VASCULARIZATION;

ANIMALS; CEREBROVASCULAR CIRCULATION; COLLATERAL CIRCULATION; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIA; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 55449099965     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/01.RES.0000338258.90706.2c     Document Type: Editorial

References (25)

1. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med. 1990;172:1535-1545.
2. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel N, Haymore BL, Leimgruber R, Feder J. Human vascular permeability factor. Isolation from U937 cells. J Biol Chem. 1989;264:20017-20024.
3. Olander JV, Connolly DT, DeLarco JE. Specific binding of vascular permeability factor to endothelial cells. Biochem Biophys Res Commun. 1991;175:68-76.
4. Connolly DT. Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem. 1991;47:219-223.
5. Pekala P, Marlow M, Heuvelman D, Connolly D. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J Biol Chem. 1990;265: 18051-18054.
6. Plouet J, Moukadiri H. Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. J Biol Chem. 1990;265:22071-22074.
7. Plouet J, Moukadiri H. Specific binding of vasculotropin to bovine brain capillary endothelial cells. Biochimie. 1990;72:51-55.
8. Rosenthal RA, Megyesi JF, Henzel WJ, Ferrara N, Folkman J. Conditioned medium from mouse sarcoma 180 cells contains vascular endo-thelial growth factor. Growth Factors. 1990;4:53-59.
9. Katoh Y, Katoh M. Comparative integromics on VEGF family members. Int J Oncol. 2006;28:1585-1589.
10. Ladomery MR, Harper SJ, Bates DO. Alternative splicing in angio-genesis: the vascular endothelial growth factor paradigm. Cancer Lett. 2007;249:133-142.
11. Pritchard-Jones RO, Dunn DB, Qiu Y, Varey AH, Orlando A, Rigby H, Harper SJ, Bates DO. Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Br J Cancer. 2007;97:223-230.
12. Flamme I, Breier G, Risau W. Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Dev Biol. 1995;169: 699-712.
13. Risau W. Angiogenesis and endothelial cell function. Arzneimittelforschung. 1994;44:416-417.
14. Huss R, Heil M, Moosmann S, Ziegelhoeffer T, Sagebiel S, Seliger C, Kinston S, Gottgens B. Improved arteriogenesis with simultaneous skeletal muscle repair in ischemic tissue by SCL( + ) multipotent adult progenitor cell clones from peripheral blood. J Vasc Res. 2004;41: 422-431.
15. Babiak A, Schumm AM, Wangler C, Loukas M, Wu J, Dombrowski S, Matuschek C, Kotzerke J, Dehio C, Waltenberger J. Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion. Cardiovasc Res. 2004;61: 789-795.
16. Tomanek RJ, Holifield JS, Reiter RS, Sandra A, Lin JJ. Role of VEGF family members and receptors in coronary vessel formation. Dev Dyn. 2002;225:233-240.
17. Tomanek RJ, Ratajska A, Kitten GT, Yue X, Sandra A. Vascular endothelial growth factor expression coincides with coronary vasculogenesis and angiogenesis. Dev Dyn. 1999;215:54-61.
18. Tomanek RJ, Lotun K, Clark EB, Suvarna PR, Hu N. VEGF and bFGF stimulate myocardial vascularization in embryonic chick. Am J Physiol. 1998;274:H1620-H1626.
19. Toyota E, Warltier DC, Brock T, Ritman E, Kolz C, O?Malley P, Rocic P, Focardi M, Chilian WM. Vascular endothelial growth factor is required for coronary collateral growth in the rat. Circulation. 2005;112: 2108-2113.
20. Chalothorn D, Clayton JA, Zhang H, Pomp D, Faber JE. Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains. Physiol Genomics. 2007;30:179-191.
21. Lloyd PG, Prior BM, Li H, Yang HT, Terjung RL. VEGF receptor antagonism blocks arteriogenesis, but only partially inhibits angiogenesis, in skeletal muscle of exercise-trained rats. Am J Physiol Heart Circ Physiol. 2005;288:H759-H768.
22. Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res. 2001;49:568-581. (Pubitemid 32146420)
23. Ishida A, Murray J, Saito Y, Kanthou C, Benzakour O, Shibuya M, Wijelath ES. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol. 2001;188:359-368.
24. Clayton JA, Chalothorn D, Faber JE. Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia. Circ Res. 2008;103:1027-1036.
25. Zbinden S, Clavijo LC, Kantor B, Morsli H, Cortes GA, Andrews JA, Jang GJ, Burnett MS, Epstein SE. Interanimal variability in preexisting collaterals is a major factor determining outcome in experimental angiogenesis trials. Am J Physiol Heart Circ Physiol. 2007;292:H1891-H1897.